Daily Newsletter

29 September 2023

Daily Newsletter

29 September 2023

Inspira to unveil new INSPIRA ART medical devices

The US FDA or any other regulatory entity has not yet approved the company’s products.

RanjithKumar Dharma September 29 2023

Inspira Technologies is set to unveil its new INSPIRA ART line of medical devices at the Extracorporeal Life Support Organisation Conference in Seattle, US.

The conference is being held between 28 September and 1 October.

Inspira’s new line consists of the INSPIRA ART100 and INSPIRA ART500 devices.

INSPIRA ART100 device is intended for patients undergoing cardiopulmonary bypass procedures.

This device is anticipated to obtain clearance from the US Food and Drug Administration (FDA) in the first half of next year.

The company is presently preparing plans for making the device available in the US.

The INSPIRA ART500 device is being developed to offer acute respiratory support for patients requiring legacy mechanical ventilation. 

The device is designed to boost blood oxygen saturation levels within minutes, even as the patient remains awake.

It is expected to provide better treatment for the 20 million patients with severe breathing problems per year.

Recently, the corporation has entered a partnership with US-based Perfusion Solution, which offers advanced medical device platforms, staffing and training to hospitals in the US.

Inspira is focused on the development of blood circulation technology, as well as artificial intelligence-driven monitoring and analytics to deliver patient-centric and data-driven solutions.

The FDA or any other regulatory entity has not yet approved the company’s products. They have also not yet been tested or used on human subjects.

Generative AI set to transform the medical devices industry

Generative AI can improve personalized healthcare by collecting data from patients via wearable devices, which can provide continuous, real-time data that can complement traditional data sources such as imaging, patient records, and more. It can also enhance existing imaging techniques by generating high-quality images of organs using data from low-resolution images (such as ultrasounds). However, the collection and use of patient healthcare data through AI medical products could conflict with regulations around the globe.

Newsletters by sectors

close

Sign up to the newsletter: In Brief

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close